Apple hypes iPhone radiology application
OK radiologists, listen up. And watchyour iPhone screen, too, because itmay soon be filled with an image you’llneed to interpret.
OK radiologists, listen up. And watch your iPhone screen, too, because it may soon be filled with an image you’ll need to interpret. At least that’s the message from Apple, whose latest television ad includes the phrase, “If you want to read an MRI, there is an app for that.”
The application is called OsiriX. It is open-source Macintosh-compatible software for medical imaging data display and manipulation.
An Apple official said OsiriX for iPhone caters to neurosurgeons, cardiologists, and ER physicians as well as radiologists. Even consumers can use an iPhone for fast access to their personal imaging records. Health Insurance Portability and Accountability Act privacy implications have not been fully explored, however.
The only way for us to know if radiologists are buying the concept is to ask you directly. Do you use OsiriX, or some other clinical imaging viewing application, on your iPhone or other smart phone? Share your experience with us by sending an e-mail message to james.brice@cmpmedica.com
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
